Cost-Effectiveness of Magnetic Resonance Imaging-Guided Thrombolysis for Patients With Stroke With Unknown Time of Onset
Louisa-Kristin Muntendorf(Universität Hamburg), Götz Thomalla(Universität Hamburg), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Salvador Pedraza(Hospital Clínic de Barcelona), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Keith W. Muir(University of Glasgow), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Alexander Konnopka(Universität Hamburg), Martin Ebinger(Universität Hamburg), Christian Gerloff(Universität Hamburg), Jochen B. Fiebach(Pathodiagnostik Berlin), Claus Z. Simonsen(Universität Hamburg), Matthias Endres(German Center for Neurodegenerative Diseases), Hans‐Helmut König(Universität Hamburg), Florent Boutitie(Université Claude Bernard Lyon 1)
Cited by 6
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856